These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11718607)

  • 1. Pharmaceutical manufacturer sponsorship and drug information.
    Basch EM; Bonfiglio MF
    Arch Intern Med; 2001 Nov; 161(21):2625-6. PubMed ID: 11718607
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of information and of decision-making in the field of supply and consumption of medical preparations.
    Kis GS
    Sante Publique (Bucur); 1980; 23(2):73-80. PubMed ID: 7209743
    [No Abstract]   [Full Text] [Related]  

  • 3. Funding of patients' groups.
    Slevin M
    Lancet; 2006 Jul; 368(9531):202. PubMed ID: 16844488
    [No Abstract]   [Full Text] [Related]  

  • 4. [Offer for better drug information].
    Højgaard L
    Ugeskr Laeger; 1994 Feb; 156(6):832-3. PubMed ID: 8016994
    [No Abstract]   [Full Text] [Related]  

  • 5. Sponsorship of patients' groups by drug companies should be made transparent.
    Tuffs A
    BMJ; 2006 Dec; 333(7581):1238. PubMed ID: 17170403
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug safety on trial.
    Nature; 2005 Mar; 434(7033):545. PubMed ID: 15800579
    [No Abstract]   [Full Text] [Related]  

  • 7. How to ask drug companies for help.
    Hayes JD
    Am J Nurs; 1993 Jan; 93(1):38-41. PubMed ID: 8447345
    [No Abstract]   [Full Text] [Related]  

  • 8. Using information services to gain a competitive advantage.
    Malloy S
    Biotechnology (N Y); 1994 Dec; 12(13):1381-4. PubMed ID: 7765571
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hotel-based medicine.
    Greenwald R
    J Rheumatol; 2009 Feb; 36(2):456; author reply 456-7. PubMed ID: 19208583
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential savings of consulting a drug information center.
    Lyrvall H; Nordin C; Jonsson E; Alvan G; Ohman B
    Ann Pharmacother; 1993 Dec; 27(12):1540. PubMed ID: 7905758
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulating manufacturer-affiliated communication in the information age.
    Schulman KA; Abernethy DR; Rathore SS; Woosley RL
    Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
    [No Abstract]   [Full Text] [Related]  

  • 13. WMA sets rules on how doctors handle industry sponsorship.
    Kmietowicz Z
    BMJ; 2004 Oct; 329(7471):876. PubMed ID: 15485951
    [No Abstract]   [Full Text] [Related]  

  • 14. If the Facts Were Not Untruths, Their Implications Were: Sponsorship Bias and Misleading Communication.
    Steel D
    Kennedy Inst Ethics J; 2018; 28(2):119-144. PubMed ID: 30100597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A database worth saving.
    Jick H
    Lancet; 1997 Oct; 350(9084):1045-6. PubMed ID: 10213544
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: limitations of the physicians' desk reference 2007.
    Mindel JS; Teich SA; Teich CM; Beam P
    Surv Ophthalmol; 2008; 53(1):82-4. PubMed ID: 18191659
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Rosenthal M
    J Health Serv Res Policy; 2004 Jan; 9(1):39-42; discussion 41-2. PubMed ID: 15006239
    [No Abstract]   [Full Text] [Related]  

  • 18. The responsibility of contrast media companies in the costs and benefits of radiology: giving the radiologist a real choice.
    Idée AS; Bonnemain B; Briand YP
    Acad Radiol; 1996 Apr; 3 Suppl 1():S157-9. PubMed ID: 8796550
    [No Abstract]   [Full Text] [Related]  

  • 19. Cochrane at crossroads over drug company sponsorship.
    Moynihan R
    BMJ; 2003 Oct; 327(7420):924-6. PubMed ID: 14563759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Compendium of Pharmaceuticals and Specialties: a critical analysis.
    Bell RW; Osterman JW
    Int J Health Serv; 1983; 13(1):107-18. PubMed ID: 6832868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.